NCT00783042View on ClinicalTrials.gov

Exploratory Study of Coronary Flow Reserve Measurements, a Non-Invasive Method for Coronary Function Measurements

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

80

Participants

Timeline

Start Date

October 31, 2008

Study Completion Date

May 31, 2009

Conditions

AtherosclerosisInflammatory Activity in Coronary Arteries

Interventions

DRUG

Rosuvastatin

40 mg, tablet, oral, once daily for 1 (double blind) +2 months (open).

DRUG

Placebo

Tablet, oral, once daily for 1 month (double blind)

Trial Locations (1)

Unknown

Research Site, Gothenburg

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY